Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curadem is a dermatological product line developed by GABRI LABS, a company specializing in therapeutic ENT and dermatology solutions. Formulated primarily as an over-the-counter (OTC) topical spray and cream, Curadem is classified as a medical device in various jurisdictions. It is designed for the prevention and treatment of various skin conditions, specifically targeting dermatological rashes and localized skin irritations. The product is manufactured in facilities across Europe and the Middle East, including the Dubai Science Park. As a commercial-stage consumer healthcare product rather than a prescription drug candidate, its specific molecular targets and pharmacologic mechanisms are not publicly detailed, with its efficacy likely derived from barrier-forming or soothing topical properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Curadem.